{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:10:37Z","timestamp":1787508637648,"version":"build-2736575974"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The effectiveness of quinolone prophylaxis in high-risk hematological pediatric patients is controversial. A systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, including studies that involved children and young adults undergoing chemotherapy for acute leukemia or hematopoietic stem cell transplantation (HSCT) who received quinolone prophylaxis compared with no prophylaxis. A meta-analysis was performed on bloodstream infections and neutropenic fever. Data regarding the impact of prophylaxis on overall survival, antibiotic exposure, antibiotic-related adverse effects, antibiotic resistance, Clostridium difficile infections, fungal infections, length of hospitalization, and costs were reviewed in the descriptive analysis. Sixteen studies were included in the qualitative analysis, and 10 of them met the criteria for quantitative analysis. Quinolone prophylaxis was effective in reducing the rate of bloodstream infections and neutropenic fever in pediatric acute leukemia compared with no prophylaxis, but it had no significant effect in HSCT recipients. Prophylaxis was associated with a higher rate of bacterial resistance to fluoroquinolones and higher antibiotic exposure.<\/jats:p>","DOI":"10.1093\/ofid\/ofac594","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T14:28:35Z","timestamp":1667485715000},"source":"Crossref","is-referenced-by-count":25,"title":["Effectiveness of Quinolone Prophylaxis in Pediatric Acute Leukemia and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"9","author":[{"given":"Davide","family":"Leardini","sequence":"first","affiliation":[{"name":"Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Muratore","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Abram","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-7288","authenticated-orcid":false,"given":"Francesco","family":"Baccelli","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Belotti","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Prete","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gori","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"2022120715564380800_ofac594-B1","doi-asserted-by":"crossref","first-page":"e27978","DOI":"10.1002\/pbc.27978","article-title":"Outcomes after bloodstream infection in hospitalized pediatric hematology\/oncology and stem cell transplant patients","volume":"66","author":"Dandoy","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"2022120715564380800_ofac594-B2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"2022120715564380800_ofac594-B3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ajic.2013.03.299","article-title":"Health care-associated infections in hematology-oncology patients with neutropenia: a method of surveillance","volume":"41","author":"Ibrahim","year":"2013","journal-title":"Am J Infect Control"},{"key":"2022120715564380800_ofac594-B4","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1182\/blood-2007-05-091942","article-title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia","volume":"110","author":"Sung","year":"2007","journal-title":"Blood"},{"key":"2022120715564380800_ofac594-B5","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022120715564380800_ofac594-B6","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"key":"2022120715564380800_ofac594-B7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"key":"2022120715564380800_ofac594-B8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"key":"2022120715564380800_ofac594-B9","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-02278-5","volume-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","author":"Carreras","year":"2019"},{"key":"2022120715564380800_ofac594-B10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/16078454.2019.1589706","article-title":"Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis","volume":"24","author":"Owattanapanich","year":"2019","journal-title":"Hematology"},{"key":"2022120715564380800_ofac594-B11","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(20)30725-7","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Lehrnbecher","year":"2021","journal-title":"Lancet Oncol"},{"key":"2022120715564380800_ofac594-B12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/ejh.13162","article-title":"Antibiotic prophylaxis in neutropenic children with acute leukemia: do the presently available data really support this practice?","volume":"101","author":"Calitri","year":"2018","journal-title":"Eur J Haematol"},{"key":"2022120715564380800_ofac594-B13","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.bbmt.2018.07.030","article-title":"Antibiotic exposure and reduced short chain fatty acid production after hematopoietic stem cell transplant","volume":"24","author":"Romick-Rosendale","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022120715564380800_ofac594-B14","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/bloodadvances.2021005129","article-title":"Gut microbiome in pediatric acute leukemia: from predisposition to cure","volume":"5","author":"Masetti","year":"2021","journal-title":"Blood Adv"},{"key":"2022120715564380800_ofac594-B15","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1017\/S0950268819001845","article-title":"Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies","volume":"147","author":"Garrido","year":"2019","journal-title":"Epidemiol Infect"},{"key":"2022120715564380800_ofac594-B16","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.3390\/jcm11154545","article-title":"Antimicrobial stewardship interventions in pediatric oncology: a systematic review","volume":"11","author":"Muratore","year":"2022","journal-title":"J Clin Med"},{"key":"2022120715564380800_ofac594-B17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s40168-021-01100-2","article-title":"Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation","volume":"9","author":"Ingham","year":"2021","journal-title":"Microbiome"},{"key":"2022120715564380800_ofac594-B18","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2022120715564380800_ofac594-B19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pbc.25335","article-title":"Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel","volume":"62","author":"Haeusler","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2022120715564380800_ofac594-B20","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022120715564380800_ofac594-B21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2022120715564380800_ofac594-B22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2022120715564380800_ofac594-B23","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's Tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2022120715564380800_ofac594-B24","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0.","author":"Higgins","year":"2011"},{"key":"2022120715564380800_ofac594-B25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"2022120715564380800_ofac594-B26","doi-asserted-by":"crossref","first-page":"e28469","DOI":"10.1002\/pbc.28469","article-title":"Cost-effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia","volume":"67","author":"McCormick","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"2022120715564380800_ofac594-B27","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/INF.0000000000000591","article-title":"Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia","volume":"34","author":"Felsenstein","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2022120715564380800_ofac594-B28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pbc.20065","article-title":"A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia","volume":"43","author":"Yousef","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"2022120715564380800_ofac594-B29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jiac.2017.12.012","article-title":"Does ciprofloxacin prophylaxis during chemotherapy induce intestinal microflora resistance to ceftazidime in children with cancer?","volume":"24","author":"Tunyapanit","year":"2018","journal-title":"J Infect Chemother"},{"key":"2022120715564380800_ofac594-B30","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1002\/cam4.3249","article-title":"Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia","volume":"9","author":"Karol","year":"2020","journal-title":"Cancer Med"},{"key":"2022120715564380800_ofac594-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JBM.S33906","article-title":"Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia","volume":"4","author":"Widjajanto","year":"2013","journal-title":"J Blood Med"},{"key":"2022120715564380800_ofac594-B32","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2666-5247(20)30202-0","article-title":"Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis","volume":"2","author":"Margolis","year":"2021","journal-title":"Lancet Microbe"},{"key":"2022120715564380800_ofac594-B33","doi-asserted-by":"crossref","first-page":"e29525","DOI":"10.1002\/pbc.29525","article-title":"Levofloxacin prophylaxis for pediatric leukemia patients: longitudinal follow-up for impact on health care-associated infections","volume":"69","author":"Davis","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"2022120715564380800_ofac594-B34","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.jtct.2021.11.017","article-title":"Safety and efficacy of prophylactic levofloxacin in pediatric and adult hematopoietic stem cell transplantation patients","volume":"28","author":"Gardner","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2022120715564380800_ofac594-B35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/ctr.12635","article-title":"Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation","volume":"29","author":"Hafez","year":"2015","journal-title":"Clin Transplant"},{"key":"2022120715564380800_ofac594-B36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5581\/1516-8484.20140011","article-title":"Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit","volume":"36","author":"Lopes","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"2022120715564380800_ofac594-B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-00725-5","article-title":"Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia","volume":"11","author":"Yeh","year":"2021","journal-title":"Sci Rep"},{"key":"2022120715564380800_ofac594-B38","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"},{"key":"2022120715564380800_ofac594-B39","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/cid\/cix644","article-title":"Clinical infectious diseases levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia","volume":"65","author":"Wolf","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022120715564380800_ofac594-B40","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","article-title":"Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy","volume":"32","author":"Laoprasopwattana","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2022120715564380800_ofac594-B41","doi-asserted-by":"crossref","first-page":"995\u20131004","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"key":"2022120715564380800_ofac594-B42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"},{"key":"2022120715564380800_ofac594-B43","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"},{"key":"2022120715564380800_ofac594-B44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF01967014","article-title":"Side-effects of quinolones: comparisons between quinolones and other antibiotics","volume":"10","author":"Norrby","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022120715564380800_ofac594-B45","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"key":"2022120715564380800_ofac594-B46","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/AAC.49.12.5189.2005","article-title":"Levofloxacin and moxifloxacin increase human gut colonization by Candida species","volume":"49","author":"Samonis","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2022120715564380800_ofac594-B47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"key":"2022120715564380800_ofac594-B48","article-title":"Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the Stem Cell Transplant and the Infectious Disease Working Groups of the AIEOP Network","author":"Zama","journal-title":"Bone Marrow Transplant."},{"key":"2022120715564380800_ofac594-B49","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1038\/s41598-019-42222-w","article-title":"Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"9","author":"D'Amico","year":"2019","journal-title":"Sci Rep"},{"key":"2022120715564380800_ofac594-B50","doi-asserted-by":"crossref","first-page":"14307","DOI":"10.1038\/s41598-021-93571-4","article-title":"Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"11","author":"Masetti","year":"2021","journal-title":"Sci Rep"},{"key":"2022120715564380800_ofac594-B51","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719896961","article-title":"Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation","volume":"11","author":"Zama","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"2022120715564380800_ofac594-B52","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/cancers14081932","article-title":"Febrile neutropenia duration is associated with the severity of gut microbiota dysbiosis in pediatric allogeneic hematopoietic stem cell transplantation recipients","volume":"14","author":"Masetti","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2022120715564380800_ofac594-B53","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12879-017-2597-0","article-title":"Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study","volume":"17","author":"Kim","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2022120715564380800_ofac594-B54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12879-017-2297-9","article-title":"Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias","volume":"17","author":"Micozzi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2022120715564380800_ofac594-B55","volume-title":"Cities in the World: A New Perspective on Urbanisation. City Worlds","author":"OECD\/European Commission","year":"2020"},{"key":"2022120715564380800_ofac594-B56","doi-asserted-by":"crossref","first-page":"e28711","DOI":"10.1002\/pbc.28711","article-title":"The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Masetti","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"2022120715564380800_ofac594-B57","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms22031197","article-title":"Microbiome-derived metabolites in allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Masetti","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2022120715564380800_ofac594-B58","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac594\/46782338\/ofac594.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/12\/ofac594\/47680566\/ofac594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/12\/ofac594\/47680566\/ofac594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T12:34:40Z","timestamp":1670416480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac594\/6795258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac594","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,11,3]]},"article-number":"ofac594"}}